Month: August 2017

Bayer, J&J win third U.S. Xarelto trial

A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the third case to go to trial out of thousands of lawsuits claiming the drugmakers’ blood thinner Xarelto led to severe internal bleeding.

The verdict in U.S. District Court in Jackson, Mississippi, is a blow to thousands of patients with similar allegations against the drugmaker. The jury returned the verdict after just four hours of deliberation.

The companies also won the previous two trials on claims of risks from Xarelto.

In the latest case, plaintiff Dora Mingo claimed she suffered acute gastrointestinal bleeding after she was treated with Xarelto for a month in 2015 to prevent blood clotting following an operation.

She accused the drugmakers, who jointly developed the blood thinner, of having failed to warn about the bleeding risks and said her injuries could have been prevented had they provided adequate information.

Multidistrict Litigation – How a MDL Works

It is estimated that 15 percent of all civil lawsuits in the U.S. are part of multidistrict litigation. Many MDLs include thousands of individual lawsuits and hundreds of lawyers from different parts of the country in a single MDL case.

MDLs were created in the 1960s to relieve crowded backlogs in federal courts. They are meant to streamline the pretrial process that goes into building a case. They eliminate duplication of witness depositions — sworn testimony before a trial — and requests for discovery — the process lawyers on both sides use to obtain evidence from their opposing side.

Still have questions?

Call (877) 932-2628 and speak with one of our legal funding experts.

* Word-Use Disclaimer

Legal funding is not a loan. It is the non-recourse purchase of an equitable lien in plaintiffs’ legal claims. Words such as ‘loans,’ ‘lending,’ ‘borrow,’ etc., are used for marketing purposes only.
More info

TriMark Legal Funding LLC
1056 Green Acres Rd #102
Eugene, OR 97408